PL87673B1 - - Google Patents
Download PDFInfo
- Publication number
- PL87673B1 PL87673B1 PL1972163819A PL16381972A PL87673B1 PL 87673 B1 PL87673 B1 PL 87673B1 PL 1972163819 A PL1972163819 A PL 1972163819A PL 16381972 A PL16381972 A PL 16381972A PL 87673 B1 PL87673 B1 PL 87673B1
- Authority
- PL
- Poland
- Prior art keywords
- nitroimidazole
- alkali metal
- chloroethyl
- preparation
- alkyl radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych pochodnych 2-nitroimidazolu o ogól¬ nym wzorze 1, w którym R oznacza nizszy rod¬ nik alkilowy, Y oznacza grupe winylowa.Sposób wedlug wynalazku polega na tym, ze l-alkilo-5-(2-chloroetylo)-2-nitroimidazol poddaje sie dzialaniu mocnej zasady w obecnosci orga¬ nicznego rozpuszczalnika z otrzymaniem 1-niz.al- kilo-5-winylo-2-nitroimidazolu.Jako mocna zasade stosuje sie wodorotlenek metalu alkalicznego, trzeciorzedowa amine, alka¬ liczny alkoholan lub amid metalu alkalicznego.W opisie i zastrzezeniu termin nizszy rodnik alkilowy oznacza, rodnik alkilowy o lancuchu prostym lub rozgalezionym o 1—4 atomach wegla.Zasadniczo aktywnosc znanych zwiazków nitro- imidazolowych ogranicza sie do pierwotniaków, podczas gdy ich dzialanie w stosunku do bakterii i grzybów jest raczej male. Obecnie stwierdzono, ze zwiazki wytworzone sposobem wedlug wyna¬ lazku dzialaja na bakterie gram-dodatnie i gram- -ujemne, grzyby oraz pierwotniaki.W szczególnosci zwiazki te wykazuja aktywnosc przeciw Clostridium perfringens, Salmonella typhi, Pseudomonas aeruginosa, Diplecoeaus pneumonine, Streptococus bemolyticus, E.Coli i Mycobacterium tuberculbsis, poniewaz stezenia okolo 0,5 do okolo /ml hamuja wzrost tych mikroorganizmów in vitro. Zwiazki te sa takze aktywne w obecnosci surowicy bydlecej. Doswiadczalnie aktywnosc zwiazku opisanego ponizej w przykladzie I stwier¬ dzono na myszach zakazonych Triohomonas vagi- nalis dawka okolo 30 mg/kg podana doustnie.Biologiczna aktywnosc zwiazków, wytworzonych sposobem wedlug wynalazku wiaze sie z niska toksycznoscia, poniewaz doustna dawka LD50 dla myszy wynosi powyzej 400 mg/kg.Ponadto zwiazki wytworzone sposobem wedlug wynalazku sa dogodnymi pólproduktami stosowa¬ nymi do otrzymywania nowych farmakologicznie czynnych 2-nitroimidazoli.Nastepujace przyklady ilustruja przedmiot wy¬ nalazku.Przyklad I. W celu wytworzenia 1-metylo- -2-nitro-5-winyloimidazolu do roztworu 18,9 g l-metylo-5-(2-chloroetylo)-2-nitroimidazolu (otrzy¬ manego wedlug angielskiego opisu patentowego nr 1222 486) w 2,8 1 bezwodnego benzenu, schlo¬ dzonego do temperatury 5—10°C, dodaje sie 16,8 g~ Ill-rzed. butoksylanu potasowego. Otrzymany roz¬ twór miesza sie w ciagu 2 godzin w temperaturze —10°C. Po odsaczeniu i zatezeniu do sucha pod obnizonym cisnieniem w temperaturze ponizej 50°C otrzymuje sie oleista pozostalosc o barwie zóltej, która przemywa sie trzy razy 50 ml por¬ cjami eteru etylowego lub lekka benzyna. Otrzy¬ many produkt suszy sie pod obnizonym cisnieniem w temperaturze 40°C. Wydajnosc wynosi 12 g 87 67387 673 (ll^/o). Próba po krystalizacji z eteru etylowego posiada temperature topnienia 106—108°C.Przyklad II. W celu wytworzenia 1-ety- lo-2-nitro-5-winyloimidazolu postepuje sie wedlug sposobu opisanego w przykladzie I stosujac jako substrat 2,2 g l-etylo-5-(2-chloroetylo)-2-nitroimi- dazolu (otrzymanego wedlug angielskiego opisu patentowego nr 1222 486). W wyniku reakcji otrzy¬ muje sie 1,5 g produktu o temperaturze topnie¬ nia 45^17°C. '\' e| l:¦ ...- LZG Z-d Nr 2 Zam. 1833 110 egz. A4 Cena 10 zl PL
Claims (2)
- Zastrzezenie patentowe 1. Sposjb wytwarzania nowych pochodnych
- 2. -ni- troimicazolu o wzorze przedstawionym na rysun¬ ku, w ktirym R oznacza nizszy rodnik alkilowy, a Y oznacza grupe winylowa, znamienny tym, ze l-alkilo-5-(2-chloroetyjo)-2-nitroimidazol poddaje sie dzialaniu mocnej zasady, takiej jak wodoro¬ tlenek metalu alkalicznego, trzeciorzedowa amina, alkoholan alkaliczny lub amid metalu alkalicznego w obecnosci organicznego rozpuszczalnika. H N' N NO, R Wzór CZYTELNIA Niskiej lmmj* PL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT4297871 | 1971-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL87673B1 true PL87673B1 (pl) | 1976-07-31 |
Family
ID=11254772
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1972156990A PL82980B1 (pl) | 1971-07-30 | 1972-07-28 | |
PL1972156989A PL85190B1 (pl) | 1971-07-30 | 1972-07-28 | |
PL1972163819A PL87673B1 (pl) | 1971-07-30 | 1972-07-28 | |
PL1972175045A PL84350B1 (pl) | 1971-07-30 | 1972-07-28 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1972156990A PL82980B1 (pl) | 1971-07-30 | 1972-07-28 | |
PL1972156989A PL85190B1 (pl) | 1971-07-30 | 1972-07-28 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1972175045A PL84350B1 (pl) | 1971-07-30 | 1972-07-28 |
Country Status (27)
Country | Link |
---|---|
US (1) | US3954789A (pl) |
JP (2) | JPS5038111B1 (pl) |
AR (4) | AR199084A1 (pl) |
AT (3) | AT316545B (pl) |
AU (1) | AU462723B2 (pl) |
BE (1) | BE785024A (pl) |
CA (1) | CA997340A (pl) |
CH (4) | CH572040A5 (pl) |
CS (1) | CS180585B2 (pl) |
DD (2) | DD99995A5 (pl) |
DE (2) | DE2229248C3 (pl) |
DK (1) | DK154295C (pl) |
ES (3) | ES405341A1 (pl) |
FI (1) | FI57255C (pl) |
FR (1) | FR2148073B1 (pl) |
GB (1) | GB1362444A (pl) |
HU (2) | HU167622B (pl) |
IE (1) | IE36530B1 (pl) |
IL (1) | IL39880A (pl) |
LU (1) | LU65816A1 (pl) |
NL (2) | NL149491B (pl) |
NO (2) | NO135591C (pl) |
PL (4) | PL82980B1 (pl) |
RO (6) | RO63048A (pl) |
SE (3) | SE392615B (pl) |
SU (4) | SU463263A3 (pl) |
ZA (1) | ZA724723B (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1480192A (en) * | 1975-01-15 | 1977-07-20 | Lepetit Spa | 1-methyl-2-nitro-imidazole-5-methanol derivatives |
GB1526451A (en) * | 1976-01-27 | 1978-09-27 | Lepetit Spa | Alpha,alpha,1-trimethyl-2-nitroimidazole-5-methanol derivatives |
US4218460A (en) * | 1976-09-29 | 1980-08-19 | Basf Aktiengesellschaft | Nitroimidazoles |
US4199592A (en) * | 1978-08-29 | 1980-04-22 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-2-nitroimidazoles |
ZW24982A1 (en) * | 1981-11-30 | 1983-06-15 | Hoffmann La Roche | 2-nitroimidazoles |
JPH10338673A (ja) * | 1997-06-04 | 1998-12-22 | Nippon Bayeragrochem Kk | イソニコチン酸ヒドラジド誘導体および有害生物防除剤 |
ZA200507752B (en) | 2003-03-28 | 2007-01-31 | Threshold Pharmaceuticals Inc | Compositions and methods for treating cancer |
EP1896040B1 (en) | 2005-06-29 | 2012-08-01 | Threshold Pharmaceuticals, Inc. | Phosphoramidate alkylator prodrugs |
EP2114157B1 (en) | 2006-12-26 | 2021-05-26 | ImmunoGenesis, Inc. | Phosphoramidate alkylator prodrug for the treatment of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL124627C (pl) * | 1964-08-12 | |||
NL143227B (nl) * | 1968-11-15 | 1974-09-16 | Lepetit Spa | Werkwijze ter bereiding van imidazoolderivaten met bactericide werking. |
US3583985A (en) * | 1969-04-09 | 1971-06-08 | Richardson Merrell Inc | Nitroimidazolyl nitrones |
US3711495A (en) * | 1970-01-07 | 1973-01-16 | Merck & Co Inc | Isoxazalin-3-yl-substituted-5-nitroimidazoles |
-
1972
- 1972-06-15 DE DE2229248A patent/DE2229248C3/de not_active Expired
- 1972-06-15 DE DE2229223A patent/DE2229223C3/de not_active Expired
- 1972-06-16 BE BE785024A patent/BE785024A/xx not_active IP Right Cessation
- 1972-06-30 FI FI1864/72A patent/FI57255C/fi active
- 1972-07-05 AU AU44228/72A patent/AU462723B2/en not_active Expired
- 1972-07-05 IE IE944/72A patent/IE36530B1/xx unknown
- 1972-07-11 ZA ZA724723A patent/ZA724723B/xx unknown
- 1972-07-11 IL IL39880A patent/IL39880A/en unknown
- 1972-07-13 GB GB3288672A patent/GB1362444A/en not_active Expired
- 1972-07-20 AR AR243172A patent/AR199084A1/es active
- 1972-07-20 AR AR243170A patent/AR193999A1/es active
- 1972-07-20 AR AR243171A patent/AR193885A1/es active
- 1972-07-25 SU SU1812191A patent/SU463263A3/ru active
- 1972-07-25 SU SU1812193A patent/SU466684A3/ru active
- 1972-07-26 US US05/275,415 patent/US3954789A/en not_active Expired - Lifetime
- 1972-07-26 DK DK369072A patent/DK154295C/da not_active IP Right Cessation
- 1972-07-27 CS CS7200005305A patent/CS180585B2/cs unknown
- 1972-07-27 NL NL727210340A patent/NL149491B/xx not_active IP Right Cessation
- 1972-07-27 NL NL727210339A patent/NL148602B/xx not_active IP Right Cessation
- 1972-07-27 NO NO2693/72A patent/NO135591C/no unknown
- 1972-07-27 JP JP47075507A patent/JPS5038111B1/ja active Pending
- 1972-07-27 JP JP47075508A patent/JPS528832B1/ja active Pending
- 1972-07-27 NO NO2694/72A patent/NO135592C/no unknown
- 1972-07-28 RO RO7200079770A patent/RO63048A/ro unknown
- 1972-07-28 HU HULE663A patent/HU167622B/hu unknown
- 1972-07-28 SE SE7209898A patent/SE392615B/xx unknown
- 1972-07-28 RO RO71770A patent/RO61517A/ro unknown
- 1972-07-28 RO RO7200075751A patent/RO63453A/ro unknown
- 1972-07-28 AT AT652772A patent/AT316545B/de not_active IP Right Cessation
- 1972-07-28 AT AT652872A patent/AT315164B/de not_active IP Right Cessation
- 1972-07-28 RO RO71769A patent/RO62787A/ro unknown
- 1972-07-28 PL PL1972156990A patent/PL82980B1/pl unknown
- 1972-07-28 CH CH1127772A patent/CH572040A5/xx not_active IP Right Cessation
- 1972-07-28 CH CH1521075A patent/CH574933A5/xx not_active IP Right Cessation
- 1972-07-28 FR FR7227293A patent/FR2148073B1/fr not_active Expired
- 1972-07-28 AT AT686873A patent/AT323736B/de not_active IP Right Cessation
- 1972-07-28 CH CH1127672A patent/CH580596A5/xx not_active IP Right Cessation
- 1972-07-28 PL PL1972156989A patent/PL85190B1/pl unknown
- 1972-07-28 RO RO7200079769A patent/RO63047A/ro unknown
- 1972-07-28 CH CH1521175A patent/CH574934A5/xx not_active IP Right Cessation
- 1972-07-28 PL PL1972163819A patent/PL87673B1/pl unknown
- 1972-07-28 LU LU65816D patent/LU65816A1/xx unknown
- 1972-07-28 DD DD164754A patent/DD99995A5/xx unknown
- 1972-07-28 PL PL1972175045A patent/PL84350B1/pl unknown
- 1972-07-28 HU HULE664A patent/HU164926B/hu unknown
- 1972-07-28 DD DD164752A patent/DD99996A5/xx unknown
- 1972-07-28 SE SE7209897A patent/SE417711B/xx unknown
- 1972-07-28 RO RO7200079771A patent/RO63049A/ro unknown
- 1972-07-29 ES ES405341A patent/ES405341A1/es not_active Expired
- 1972-07-29 ES ES405343A patent/ES405343A1/es not_active Expired
- 1972-07-31 CA CA148,336A patent/CA997340A/en not_active Expired
-
1973
- 1973-06-27 SU SU7301932092A patent/SU581863A3/ru active
- 1973-08-02 AR AR249413A patent/AR199680A1/es active
- 1973-09-20 ES ES418921A patent/ES418921A1/es not_active Expired
- 1973-12-24 SU SU7301978810A patent/SU567404A3/ru active
-
1975
- 1975-03-18 SE SE7503080A patent/SE417200B/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3158635A (en) | Bis-adduction products and methods of preparing same | |
BR8502227A (pt) | Processos para a obtencao de derivados de acido piridino-2,3-dicarboxilico e de derivados de acido 1-amino-1,4-dihidropiridino-2,3-dicarboxilico | |
PL87673B1 (pl) | ||
DD244553A5 (de) | Verfahren zur herstellung von 5,6-difluor-naphthyridinen und 5,6,8-trifluorchinolinen | |
KR890000864B1 (ko) | 6,7-디히드로-5,8-디메틸-9-플루오로-1-옥소-1H,5H-벤조[ij]퀴놀리진- 2-카르복실산, 그 유도체 및 제조방법 | |
EP0496238A1 (de) | Substituierte Benzoxazepine und Benzthiazepine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
MX163528B (es) | Productos de reaccion de poli(oxialquileno)de acido succinico hidrocarbilo-substituido y/o terminados de anhidrido amina y sistemas acuosos conteniendo los mismos | |
US3917609A (en) | Pyrroloquinoline carboxylic acids and derivatives | |
CA1215713A (en) | Substituted quinolinecarboxylic acid | |
EP0028698B1 (en) | Quinoline compounds, process for their preparation, and pharmaceutical compositions | |
IE41440B1 (en) | 7-methoxy-6-thiatetracyclines and their preparation | |
DD282691A5 (de) | Verfahren zur herstellung von cephalosporin | |
EP0052910B1 (en) | Derivative of n-acetilcysteine having therapeutical activity, process for its preparation and related pharmaceutical compositions | |
US4080380A (en) | 2-Naphthyl-lower-alkylamines | |
US6576764B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
DE2203653B2 (de) | 3-Carbamoyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carbonsäure und deren Salze, Verfahren zur Herstellung dieser Verbindungen und solche Verbindungen enthaltende Arzneimittel | |
Rinderknecht et al. | The synthesis of 5-fluoro-DL-tryptophan | |
US4060527A (en) | Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives | |
FI82688C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva kinolinderivat. | |
US3494914A (en) | Antibacterial agents | |
US3594413A (en) | Cyclopentene derivatives | |
Devínský et al. | Synthesis, IR spectra and antimicrobial activity of 1, 4-dialkylpiperazine dioxides | |
KR970004044B1 (ko) | 약물동력학적으로 개선된 세팔로스포린 유도체, 그의 제조방법, 그를 함유하는 약제학적 조성물 및 합성 중간체 | |
US3716553A (en) | 1,3-diazaspiro [4,4]non-7-ene-2,4-dione | |
DE2647571A1 (de) | Neue cephalosporinderivate |